Dr. Sudarshan Ramchandran : PCSK9 Inhibitors - Beneficial in Managing Diabetic Dyslipidemia

  • 275311
    Views

Author

Dr. Sudarshan Ramchandran

Dr. Sudarshan Ramchandran
Professor, , University Hospitals, Birmingham

Disclaimer: This content is intended for qualified healthcare professionals. It does not constitute patient advice. Always consult current clinical guidelines.

Professor,


  • " PCSK9 inhibitors: effective in lowering the LDL cholesterol, "
  • " PCSK 9 inhibitors in UK are funded by the central govenrnement "
  • " Patients have shown exceptional tolerability to PCSK9 than to statins. "
Powered by:
new-poweredby-google
Awards & Recognitions:
award
1000 awards
SBC Global Logo
Start Up